obg_manag_jan_19_210.png Applying Guidelines in Practice: Noninvasive Prenatal Testing 1.0 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png Evolving Strategies in the Diagnosis and Management of Hemolytic Disease of the Fetus and Newborn 0.25 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png Expanding Contraceptive Choices for Women: The Vaginal pH Modulator 0.25 AMA PRA Category 1 Credits™ obg_manag_jan_19_210.png Ospemifene, an oral SERM for dyspareunia of menopause: Is it being underutilized? 1.0 AMA PRA Category 1 Credit(s)™
obg_manag_jan_19_210.png Applying Guidelines in Practice: Noninvasive Prenatal Testing 1.0 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png Evolving Strategies in the Diagnosis and Management of Hemolytic Disease of the Fetus and Newborn 0.25 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png Expanding Contraceptive Choices for Women: The Vaginal pH Modulator 0.25 AMA PRA Category 1 Credits™
obg_manag_jan_19_210.png Ospemifene, an oral SERM for dyspareunia of menopause: Is it being underutilized? 1.0 AMA PRA Category 1 Credit(s)™
